Synthesis, characterization, theoretical studies and cellular cytotoxicity effects of nickel (II) complexes with 3-hydroxyflavene, deferiprone, and maltol chelating ligands

In the present study, three complexes with nickel central metal and with general formula [Ni(L)2]; where L is 3-hydroxy flavone (HLf), deferiprone (HLd) and maltol (HLm); synthesized and characterized by Infrared spectroscopy, mass spectroscopy, and elemental analysis. Studies have shown three ligan...

Full description

Bibliographic Details
Published in:	شیمی کاربردی روز
Main Authors:	Seyed Mojtaba Mashmoul Moghadam, samie salehi, Mojtaba Tarin, amir shokooh saljooghi, Shamila Azmoodeh, Maryam Babaei
Format:	Article
Language:	English
Published:	Semnan University 2021-06-01
Subjects:	3-hydroxyflavene deferiprone maltol nickel (ii) dft method mtt chelation therapy
Online Access:	https://chemistry.semnan.ac.ir/article_5260_3c0190f10d5b88c4aada55768d9f627e.pdf

Similar Items

Synthesis of Deferiprone as a Widely Used Iron-Chelating Drug for the Treatment of Iron-Overload Diseases
by: Sara Sadeghian, et al.
Published: (2024-03-01)

Deferiprone–resveratrol hybrid attenuates iron accumulation, oxidative stress, and antioxidant defenses in iron-loaded human Huh7 hepatic cells
by: Jin Li, et al.
Published: (2024-03-01)

Multipurpose Iron-Chelating Ligands Inspired by Bioavailable Molecules
by: Elena Cini, et al.
Published: (2024-01-01)

Antioxidant Activity of Deferasirox and Its Metal Complexes in Model Systems of Oxidative Damage: Comparison with Deferiprone
by: Viktor A. Timoshnikov, et al.
Published: (2021-08-01)

The Best Iron Chelation Therapy in Major Thalassemia Patients is Combination of Desferrioxamine and Deferiprone
by: Mohammad Ali Mashhadi, et al.
Published: (2011-06-01)

The Best Iron Chelation Therapy in Major Thalassemia Patients is Combination of Desferrioxamine and Deferiprone
by: Ebrahim miri moghaddam, et al.
Published: (2011-04-01)

Deferiprone: new environmental perspectives. Insights into its sequestering ability vs. different metal cations
by: Anna Irto, et al.
Published: (2024-03-01)

Production and Evaluation of Lutetium-177 Maltolate as a Possible Therapeutic Agent
by: A Hakimi, et al.
Published: (2012-08-01)

Safety and efficacy of maltol belonging to chemical group 12 when used as flavouring for all animal species
by: EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), et al.
Published: (2016-11-01)

THE RELATION BETWEEN TYPES OF IRON CHELATORS AND FERITIN ON OSTEOCALCIN OF THALASSEMIA PATIENTS WITH REPEATED TRANSFUSIONS
by: Sesa Amelia, et al.
Published: (2020-01-01)

Deferiprone (DFP) Targets Cancer Stem Cell (CSC) Propagation by Inhibiting Mitochondrial Metabolism and Inducing ROS Production
by: Marco Fiorillo, et al.
Published: (2020-06-01)

Impact of Sappan Wood Extract as Iron Chelator Adjuvant on Iron Concentration and Macrophage Polarization in Rat Spleen
by: Mohammad Ghozali, et al.
Published: (2025-07-01)

The Vital Role Played by Deferiprone in the Transition of Thalassaemia from a Fatal to a Chronic Disease and Challenges in Its Repurposing for Use in Non-Iron-Loaded Diseases
by: George J. Kontoghiorghes
Published: (2023-07-01)

Maltol, a Natural Flavor Enhancer, Inhibits NLRP3 and Non-Canonical Inflammasome Activation
by: Huijeong Ahn, et al.
Published: (2022-09-01)

Comparative Efficacy of Deferiprone, Deferoxamine and Combination of Deferiprone and Deferoxamine on Serum Ferritin Value in Beta-Thalassemia Patients
by: Nargesbeygom Mirbehbahani, et al.
Published: (2015-01-01)

The Influence of Pervaporation on Ferulic Acid and Maltol in Dealcoholised Beer
by: Mateusz Jackowski, et al.
Published: (2024-10-01)

Effects of iron chelation therapy on the clinical course of aceruloplasminemia: an analysis of aggregated case reports
by: Lena H. P. Vroegindeweij, et al.
Published: (2020-04-01)

Collation of Anticancer Activities for Benzo/Hydroxypyrone Ligands and Copper(II) Complex with Maltol on 2D Cell Models In Vitro
by: Nikolina Filipović, et al.
Published: (2023-11-01)

Effect of iron chelating drug, Deferiprone and the water extract of green tea in the treatment of iron overload in local rabbits
by: Zaid Mohammed Mubarak Al-Mahdawi, et al.
Published: (2019-01-01)

Combination iron chelation therapy with deferiprone and deferasirox in iron-overloaded patients with transfusiondependent β-thalassemia major
by: Hossein Karami, et al.
Published: (2017-01-01)

Deferiprone, an iron chelator, alleviates platelet hyperactivity in patients with β-thalassaemia/HbE
by: Ngan Thi Tran, et al.
Published: (2022-12-01)

The Antimicrobial Mode of Action of Maltol and Its Synergistic Efficacy with Selected Cationic Surfactants
by: Noa Ziklo, et al.
Published: (2021-09-01)

Deferiprone-induced arthropathy in thalassemia: MRI findings in a case
by: Gyan Chand, et al.
Published: (2009-04-01)

A Model of Time-dependent Biodistribution of 153Sm-Maltolate Complex and Free 153Sm Cation Using Compartmental Analysis
by: Amir Hakimi, et al.
Published: (2016-04-01)

Deferiprone ameliorates cisplatin induced peripheral neurotoxicity via ferritinophagy adjustment
by: Hanan Seddiek, et al.
Published: (2025-02-01)

Assessment of the effect of combination therapy with Deferiprone & Desferrioxamine on cardiac complications in major Thalassemia
by: F. Rashidi ghader, M.D, et al.
Published: (2007-01-01)

Playing with Structural Parameters: Synthesis and Characterization of Two New Maltol-Based Ligands with Binding and Antineoplastic Properties
by: Eleonora Macedi, et al.
Published: (2020-02-01)

Adherence to Iron Chelation Therapy and Its Determinants
by: Sukhmani Sidhu, et al.
Published: (2021-01-01)

On the Role of Iron in Idiopathic Parkinson’s Disease
by: Sandro Huenchuguala, et al.
Published: (2023-11-01)

Pharmacological iron-chelation as an assisted nutritional immunity strategy against Piscirickettsia salmonis infection
by: Mario Caruffo, et al.
Published: (2020-10-01)

Newly identified maltol derivatives in Korean Red Ginseng and their biological influence as antioxidant and anti-inflammatory agents
by: Jeong Hun Cho, et al.
Published: (2023-07-01)

Amphetamine-like Deferiprone and Clioquinol Derivatives as Iron Chelating Agents
by: Mahmoud El Safadi, et al.
Published: (2024-09-01)

New Approaches and Strategies for the Repurposing of Iron Chelating/Antioxidant Drugs for Diseases of Free Radical Pathology in Medicine
by: George J. Kontoghiorghes
Published: (2025-08-01)

Controlled release of gallium maltolate complex from injectable phosphocalcic cements
by: Manon Dupleichs, et al.
Published: (2022-01-01)

Antiplatelet activity of deferiprone through cyclooxygenase-1 inhibition
by: Ngan Thi Tran, et al.
Published: (2020-05-01)

Effects of combined deferiprone with deferoxamine on right ventricular function in thalassaemia major
by: Alpendurada Francisco, et al.
Published: (2012-01-01)

Challenges of Iron Chelation in Thalassemic Children
by: Alkistis Adramerina, et al.
Published: (2024-02-01)

Maltol Improves APAP-Induced Hepatotoxicity by Inhibiting Oxidative Stress and Inflammation Response via NF-κB and PI3K/Akt Signal Pathways
by: Zi Wang, et al.
Published: (2019-09-01)

One-step determination of total iron using deferiprone or kojic acid as colorimetric reagents
by: Rosita Cappai, et al.
Published: (2024-01-01)

A pilot trial of deferiprone in pantothenate kinase-associated neurodegeneration patients
by: Mohammad Rohani, et al.
Published: (2018-02-01)